Study to test Levothyroxine Formulation in Hypothyroid Patients


The purpose of this study is to test a liquid levothyroxine formula and examine if it will lead to improvement in management of thyroid function and if it improves hypothyroid symptoms that patients experience. 

The trial officially began on the May 5, 2021 and is planned to complete on April 2023.

The population that can be enrolled into this study includes:

  • Adults age 18 years old or older
  • G-tube/G-J tube dependent for medication administration - Hypothyroid patients on levothyroxine tablet
  • TSH>5 on levothyroxine.

    Exclusion Criteria:
  • J-tube
  • Unstable cardiac condition
  • Unstable gastrointestinal condition
  • Unable to reliably administer medication
  • Screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
  • In the opinion of the study investigator, any subject who demonstrate a risk of non-compliance with study procedure, or one who cannot read, understand or complete study - related materials.

The link to the complete study profile:

Clinical Research News

Upcoming Clinical Trials